Zusammenfassung
Die Urtikaria repräsentiert eine der häufigsten dermatologischen Erkrankungen, die durch das transiente Auftreten von juckenden Urtikae charakterisiert wird. Die Empfindung des Pruritus wird von Patienten mit chronischer Urtikaria als kribbelnd, brennend oder stechend angegeben. Da die Pruritusattacken und das Auftreten von Urtikae nicht vorhersehbar sind, beeinflusst die Urtikaria die Lebensqualität der Patienten stark. In diesem Überblick fokussieren wir uns auf die klinischen Charakteristika, therapeutischen Optionen sowie neue pathophysiologische Mechanismen wie das T-Zell-Zytokin IL-31 beim Pruritus von Patienten mit chronischer Urtikaria.
Abstract
Urticaria is a frequent dermatological skin disease characterized by the occurrence of transient pruritic wheals. The sensation of pruritus has been described to be stinging, tickling and burning in patients with chronic urticaria. Because of the unpredictable attacks of pruritus and swelling, urticaria strongly affects the quality of life in patients. In this review we focus on clinical characteristics, therapeutic options and new pathophysiological mechanisms including the novel T-cell cytokine IL-31 in pruritus of patients with chronic urticaria.
Literatur
Ikoma A, Steinhoff M, Stander S et al (2006) The neurobiology of itch. Nat Rev Neurosci 7(7):535–547
Stander S, Schmelz M (2006) Chronic itch and pain – similarities and differences. Eur J Pain 10(5):473–478
Frey M v. (1922) Zur Physiologie der Juckempfindung. Arch Neerl Physiol 7:142–145
Schmelz M, Schmidt R, Bickel A et al (1997) Specific C-receptors for itch in human skin. J Neurosci 17(20):8003–8008
Namer B, Carr R, Johanek LM et al (2008) Separate peripheral pathways for pruritus in man. J Neurophysiol 100(4):2062–2069
Raap U, Kapp A (2005) Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 5(5):419–424
Raap U, Ikoma A, Kapp A (2006) Neurophysiology of pruritus. Hautarzt 57(5):379–374
Raap U, Ständer S (2010) Pruritus and skin: new insights in the pathomechanism of pruritus. Allergo J 19:58–65
Fuchs R (1900) Hippokrates, sämtliche Werke. H. Lüneburg
Yosipovitch G, Ansari N, Goon A et al (2002) Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 147(1):32–36
O’Donnell BF, Lawlor F, Simpson J et al (1997) The impact of chronic urticaria on the quality of life. Br J Dermatol 136(2):197–201
Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64(10):1417–1426
Darsow U, Scharein E, Simon D et al (2001) New aspects of itch pathophysiology: component analysis of atopic itch using the „Eppendorf Itch Questionnaire“. Int Arch Allergy Immunol 124(1–3):326–331
Dijkstra D, Leurs R, Chazot P et al (2007) Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol 120(2):300–307
Gutzmer R, Mommert S, Gschwandtner M et al (2009) The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol 123(3):619–625
Rossbach K, Wendorff S, Sander K et al (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18(1):57–63
Groneberg DA, Serowka F, Peckenschneider N et al (2005) Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 161(1–2):87–92
Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237(4819):1154–1162
Raap U, Deneka N, Bruder M et al (2008) Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects. Clin Exp Allergy 38(9):1493–1498
Stander S, Weisshaar E, Steinhof M et al (2003) Pruritus – pathophysiology, clinical features and therapy – an overview. J Dtsch Dermatol Ges 1(2):105–118
Jorizzo JL, Coutts AA, Eady RA, Greaves MW (1983) Vascular responses of human skin to injection of substance P and mechanism of action. Eur J Pharmacol 87(1):67–76
Hakim-Rad K, Metz M, Maurer M (2009) Mast cells: makers and breakers of allergic inflammation. Curr Opin Allergy Clin Immunol 9(5):427–430
Caproni M, Giomi B, Melani L et al (2006) Cellular infiltrate and related cytokines, chemokines, chemokine receptors and adhesion molecules in chronic autoimmune urticaria: comparison between spontaneous and autologous serum skin test induced wheal. Int J Immunopathol Pharmacol 19(3):507–515
Kobayashi H, Gleich GJ, Butterfield JH, Kita H (2002) Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 99(6):2214–2220
Raap U, Goltz C, Deneka N et al (2005) Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J Allergy Clin Immunol 115(6):1268–1275
Solomon A, Aloe L, Pe’er J et al (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 102(3):454–460
Noga O, Englmann C, Hanf G et al (2002) Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clin Exp Allergy 32(9):1348–1354
Micera A, Vigneti E, Pickholtz D et al (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98(11):6162–6167
Raap U, Werfel T, Goltz C et al (2006) Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy 61(12):1416–1418
Dillon SR, Sprecher C, Hammond A et al (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5(7):752–760
Raap U, Wieczorek D, Gehring M et al (2010) Increased levels of serum IL-31 in chronic spontaneous urticaria. Exp Dermatol 19(5):464–466
Raap U, Wichmann K, Bruder M et al (2008) Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122(2):421–423
Sonkoly E, Muller A, Lauerma AI et al (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117(2):411–417
Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 64(10):1427–1443
Siebenhaar F, Degener F, Zuberbier T et al (2009) High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 123(3):672–679
Phan NQ, Bernhard JD, Luger TA, Stander S (2010) Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. J Am Acad Dermatol (im Druck)
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raap, U., Kapp, A., Wedi, B. et al. Pruritus bei Urtikaria. Hautarzt 61, 737–742 (2010). https://doi.org/10.1007/s00105-010-1931-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-010-1931-x